PubMed ID:
22775763
Public Release Type:
Journal
Publication Year: 2012
Affiliation: Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA. myra_carpenter@unc.edu
DOI:
https://doi.org/10.1111/j.1399-0012.2012.01676.x
Authors:
Adey DB,
Bostom AG,
Carpenter MA,
House AA,
Kusek JW,
Weir MR
Studies:
Folic Acid for Vascular Outcome Reduction in Transplantation Trial
Kidney transplant recipients (KTRs) have increased risk of cardiovascular disease (CVD). Our objective is to describe the prevalence of CVD risk factors applying standard criteria and use of CVD risk factor-lowering medications in contemporary KTRs.